Disorders of venous blood flow as a cause of chronic abacterial prostatitis (chronic pelvic pain syndrome)

Patients with chronic abacterial prostatitis (chronic pelvic pain syndrome) (CAP/CPPS) is one of the most problematic categories of patients. There are some papers on arterial and venous disorders of the prostate as the main cause of this pathology. The present study has assessed the effectiveness of phlebotropic therapy in patients with long-standing CAP/CPPS on the background of pelvic varicose veins. Inclusion criteria were symptoms of CAP/CPPS more than 1 year with failure of the treatment in accordance with the RSU recommendations. The study included 96 patients aged 33.2±5.3 years. Duration of disease was 20.3±4.6 months. The patients were divided into 3 groups depending on the treatment received. In group 1 (n=33), patients have received a comprehensive phlebotropic therapy, in the group 2 (n=31) - phlebotropic therapy and ProstaDoz, in group 3 (n=32) - standard therapy and ProstaDoz. Elimination of regional phlebohypertension led to a marked improvement in all sections of the NIH-CPSI questionnaire, strengthening of intraprostatic blood flow, normalization of fructose and zinc levels in ejaculate, normalization of ejaculate volume, with maintaining the effects after cessation of treatment. Additional treatment with ProstaDoz in group 2 increased therapeutic effect, making the differences in the biochemical analysis of ejaculate to be statistically significant compared with group 1. In the group 3, the effect was significantly less pronounced and unstable, vascular changes were virtually absent.

chronic pelvic pain syndrome, chronic prostatitis, pelvic varicose veins